Put companies on watchlist
Corcept Therapeutics
ISIN: US2183521028
WKN: 529882
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Corcept Therapeutics · ISIN: US2183521028 · PR Newswire (ID: 20240826DC90798)
26 August 2024 04:00PM

SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Corcept Therapeutics Incorporated (NASDAQ: CORT)


NEW YORK, Aug. 26, 2024 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Corcept Therapeutics Incorporated (NASDAQ: CORT) on behalf of the company's shareholders.  The investigation seeks to determine whether Corcept's directors breached their fiduciary duties in connection with recent corporate actions.

If you are a shareholder of Corcept Therapeutics Incorporated and are interested in obtaining additional information regarding your rights and options, free of charge, please visit us at: https://pjlfirm.com/corcept-therapeutics-incorporated/

You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000.  One of our attorneys will personally speak with you about the case at no cost or obligation.

Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit https://pjlfirm.com.   Attorney advertising. Prior results do not guarantee a similar outcome. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-purcell--lefkowitz-llp-announces-shareholder-investigation-of-corcept-therapeutics-incorporated-nasdaq-cort-302229991.html

SOURCE Purcell & Lefkowitz LLP

Visual performance / price development - Corcept Therapeutics
Smart analysis and research tools can be found here.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942